LEO Pharma Inc. is the U.S. affiliate of Denmark-based LEO Pharma, a global leader in dermatology and critical care. LEO Pharma Inc. opened the U.S. affiliate in January, 2010. The offices are located in Madison, NJ. While LEO Pharma is new to the U.S., we have more than 100 years of history as an specialty pharmaceutical company committed to the discovery and development of novel drugs for patients within the areas of dermatology and critical care medicine.
LEO Pharma products have been available in the U.S. since 1994, with the launch of Dovonex® (calcipotriene 0.005%) Ointment. LEO Pharma is now aimed at establishing itself as the leader in the areas of dermatology and critical care in the U.S. with the support of more than 4,800 specialized employees globally working to develop, produce and market our drugs.
LEO Pharma is wholly owned by The LEO Foundation and the company is headquartered in Ballerup, Denmark, outside of Copenhagen, and is represented in more than 100 countries worldwide. To learn more about LEO Pharma, visit our global site at www.leo-pharma.com.